fbpx
Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

Dementia, life expectancy and nursing home care

Written by | 11 Jan 2025

Researchers from a large meta-analysis of relevant studies have reported that the average life expectancy of people with dementia at time of diagnosis ranges from 5.7 years at… read more.

The dengue vaccine is effective and safe: confirmation from the first global meta-analysis

Written by | 13 Aug 2024

The Dengue vaccine has an efficacy rate of over 50% in reducing disease cases, with lasting effects and a very good safety profile. This is confirmed by the first global meta-analysis on the efficacy of TAK-003, better… read more.

Meta-analysis shows low risk of muscle pain from statins

Written by | 31 Aug 2022

In over 90% of cases, statin therapy is not related to muscle pain, researchers from a large new study reported on August 29, 2022 in The Lancet. “The… read more.

Sight problems may increase dementia risk in older adults

Written by | 29 Jun 2022

Older adults with untreated sight conditions may be at increased risk of dementia, according to a new systematic review and meta-analysis of 16 studies involving 76,373 participants. The… read more.

Applying the results of the ivermectin meta-analysis

Written by | 12 Aug 2021

The results of the ivermectin meta-analysis could have important implications for health policy. Dr Edmund Fordham, one of the co-authors of the review, describes how the findings could… read more.

Critical questions on the ivermectin meta-analysis

Written by | 12 Aug 2021

The methodological approach to the ivermectin meta-analysis provides further reassurance of the robustness of the findings. Mr Andrew Bryant and Dr Edmund Fordham describe some of the critical… read more.

Putting the findings of the ivermectin meta-analysis into perspective

Written by | 12 Aug 2021

The Bryant-Lawrie meta-analysis included only randomised controlled trials (RCTs) but evidence from observational trials and real world experience sheds further light on the effectiveness of ivermectin, according to… read more.

Key findings from the ivermectin meta-analysis

Written by | 12 Aug 2021

June 2021 saw the publication of the systematic review and meta-analysis of randomised controlled trials of ivermectin for treatment and prophylaxis of covid-19 undertaken by Dr Tess Lawrie’s… read more.

Ivermectin – the unfolding story

Written by | 24 Jul 2021

IMI has been reporting on ivermectin since December 2020, keeping our readers and viewers up-to-date with research and practice developments. To mark World Ivermectin Day (24th July 2021),… read more.

Ivermectin meta-analysis – the findings

Written by | 26 Jan 2021

Interview and article by Christine Clark. Dr Tess Lawrie, Director of the Evidence-based Medicine Consultancy Ltd, describes the key findings from her recently-published meta-analysis of ivermectin trials for… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.